Trial intelligence / Profile preview

Peginesatide in CKD patients on dialysis

NCT01478971Phase 3Completed

Sponsor
Takeda
Start
Oct 2011
Primary completion
Feb 2013
Countries
1
01

Overview

A Phase 3 trial of peginesatide in anemia, sponsored by Takeda. Started Oct 2011; status: completed.

02

Drugs

peginesatide
03

Conditions

anemia

Beyond the preview

Go deeper on NCT01478971.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01478971.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call